Hanoi 2011
ORGANISATION
________________________________________________________________________
Hanoi Meeting 2011: Presentations
November 10, Morning
Introduction to the Workshop: Explanation of the Program WBMT /WHO
Workshop
Overview of current status of Stem Cell Transplantation In Vietnam
Prof. Nguyen Anh Tri MD., PhD., Director of NIHBT
WHO AND HSC
Dr. Luc Noel, WHO Geneva
Global perspectives of HCT including networking and macroeconomics of HCT
Dietger Niederwieser, Prof. Dr. med. Dr. h.c., University of Leipzig
Blood and Marrow Transplantation in a developing country: The Philippine Experience
Honorata G. Babylon, MD, MHA, FPCP, FPSHBT
HSCT activity in Mongolia
Otgonbat A, MD, M.Sc, Department of Hematology, HSUM
Oyundelger N, MD, Clinical Professor, SCCH
Current Situation of Hematopoietic Stem Cell Transplantation in Bangladesh
Prof. M.A.Khan, MBBS,FCPS, FRCP(Edin), Department of Hematology, Dhaka Medical College & Hospital
Ngoma A., Democratic Republic of Congo
November 10, Afternoon
Establishing a Transplant Program
Starting a HCT program – A perspective from India
Alok Srivastava, Department of Haematology, Christian Medical College
Brazil
Adriana Seber
Starting a new Transplant Program
Weisdorf
What do we need to get started?
Hildegard Greinix, Medical University of Vienna, Austria
How to start the program
R. Suzuki
Twining and teaching
Prof. E. Holler, Dp.t of Hematology/Oncology, University Medical Center Regensburg
Education & Dissemination
Eliane Gluckman
Current Indications for HCT
J. Douglas Rizzo, MD MS
Principles of Triage in HSCT Hungarian model
Tamás Masszi, Semmelweis University, St László Hospital, Budapest, Hungary
Challenges of BMT activities in Vietnam
Tran Van Binh
Indications for Transplants and Patient Selection
WBMT/WHO Workshop
November 11, early Morning
Donor choice
Eliane Gluckman
„Donor suitability and donation process”
Dietger Niederwieser, Prof. Dr. med. Dr. h.c., University of Leipzig
Pedriatic Hematopoietic Stem Cell Donors: When and How can Children Ethically Donate?
Michael A. Pulsipher, MD, Associate Professor, University of Utah School of Medicine
Preregistration and five-year follow-up system for bone marrow and peripheral blood stem cell family donors – the interim report
Miyamura K, Kim S, Nagafuji K, Hino M, Suzuki R, Kodera Y,
for the Japan Society for Hematopoietc Cell Transplantation
Donor outcome follow up a global challenge
Jörg Halter, University hospital Basel, Switzerland
BM and PBSC Donor Outcomes and Recommended Follow Up
Michael A. Pulsipher, MD, Associate Professor, University of Utah School of Medicine
Protection of the Living Donor Haematopoietic Stem Cell Transplantation
Dr. Luc Noel , Coordinator “Clinical Procedures “ HSS/HDS/CPR, World Health Organization, Geneva
Legislative Frameworks and Ethics of Donation
Jeff Szer, Royal Melbourne Hospital, Australia
HLA Compatibility and Ethnicity
Yasuo Morishima MD, Aichi Cancer Center Nagoya Japan, Japan Marrow Donor Program
„Stem cell source (related/unrelated/cord blood/haploidentical)”
Dietger Niederwieser, Prof. Dr. med. Dr. h.c., Dept. Hematology, Oncology and Hemostasis/Thrombosis,
Universität Leipzig
Stem Cell Source cord blood
Shuichi Taniguchi, Department of Hematology, Toranomon Hospit
HLA mismatched/ haploidentical HSCT without in vitro T-cell depletion for the treatment of acute leukemia
Daihong Liu, Institute of Hematology, People’s Hospital Peking University
Donor Availability: Related and Unrelated
Dennis L. Confer, MD, Chief Medical Officer National Marrow Donor Program
November 11, Morning
WBMT Graft Processing Workshop
Dr Mickey Koh, St George’s Hospital, London, UK, Health Sciences Authority, Singapore
Hematopoietic Progenitor Cell Product Characterization
Carolyn A. Taylor, Ph.D., Professor of Medicine, Director of BMT Program Cell, Processing Laboratory
The Role of the Graft Processing Laboratory in Stem Cell Transplantation
Doug Padley, MT (ASCP), Mayo Clinic, Rochester MN USA
Graft Processing Staff, Procedures, Materials and Equipment
Ms Meng Kee TAN, Quality Management Consultant, Blood Transfusion and Medical Laboratory Services,
Canada
Cord Blood Banking
Optimising Inventories Public vs Private
Dr. Susana G Gomez, Anthony Nolan Cell Therapy Centre
Advanced Graft processing
Dominic Wall PhD FFSc (RCPA), Operations Director, Centre for Blood Cell Therapies, Peter MacCallum Cancer Centre
Regulatory frameworks: HSCT and other cell and tissue therapies
Srinivasan N KELLATHUR, PhD, Pharmaceuticals and Biologics Branch, Pre-market Division Health Products Regulation Group, Health Sciences Authority
Developing an Outcomes Database Developing an Outcomes Database and Transplant Registries and Transplant Registries
Moderators: Marcelo Pasquini and Philip Rowlings
Discussion: Graft Processing Workshop
November 11, Afternoon
What is the minimum dataset suggested by APBMT for programs with limited resources?
Yoshiko Atsuta for the APBMT
Education & Dissemination 1
Eliane Gluckman
Dissemination of Information
David Ma
APBMT Least Minimum Data “LMD”
Dr Yoshiko Atsuta
Dissemination of Information
David Ma
World Marrow Donor Association Standards
Dennis L. Confer, MD
AABB Standards and Accreditation
Doug Padley, MT (ASCP), Mayo Clinic, Rochester MN USA
Inspection and Accreditation
Carolyn Taylor, PhD, Chair, FACT Standards Development Committee
EFI/ASHI Standards Accreditation – G. Fischer
Overview of Aide-Memoire: ‘Key elements’
Meng Kee Tan, Dr. Ineke Slaper-Cortenbach, Dr. Gottfried Fischer, Dr. Paul Eldridge and Kathy Loper, WBMT, WHO, NIHBT
Conclusions
Dennis L. Confer